Five years ago NNVC was one toxicity test, one phase 1 test, one phase 2 test, one phase 3 test, and one FDA approval away from having a salable product. Today NNVC is one toxicity test, one phase 1 test, one phase 2 test, one phase 3 test, and one FDA approval away from having a salable product.
What has happened over the past 5 years is that NNVC has spent a lot more of investor's money.
Hence the low stock price.